292 related articles for article (PubMed ID: 18077063)
1. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge.
Marriott KA; Parkinson CV; Morefield SI; Davenport R; Nichols R; Monath TP
Vaccine; 2008 Jan; 26(4):581-8. PubMed ID: 18077063
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.
Wei H; Huang D; Fortman J; Wang R; Shao L; Chen ZW
J Virol; 2009 Jan; 83(2):1115-25. PubMed ID: 19004937
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
4. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
Stittelaar KJ; van Amerongen G; Kondova I; Kuiken T; van Lavieren RF; Pistoor FH; Niesters HG; van Doornum G; van der Zeijst BA; Mateo L; Chaplin PJ; Osterhaus AD
J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938
[TBL] [Abstract][Full Text] [Related]
5. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
Hooper JW; Thompson E; Wilhelmsen C; Zimmerman M; Ichou MA; Steffen SE; Schmaljohn CS; Schmaljohn AL; Jahrling PB
J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
[TBL] [Abstract][Full Text] [Related]
6. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
[TBL] [Abstract][Full Text] [Related]
7. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
Denzler KL; Babas T; Rippeon A; Huynh T; Fukushima N; Rhodes L; Silvera PM; Jacobs BL
Vaccine; 2011 Dec; 29(52):9684-90. PubMed ID: 22001879
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Earl PL; Americo JL; Wyatt LS; Eller LA; Whitbeck JC; Cohen GH; Eisenberg RJ; Hartmann CJ; Jackson DL; Kulesh DA; Martinez MJ; Miller DM; Mucker EM; Shamblin JD; Zwiers SH; Huggins JW; Jahrling PB; Moss B
Nature; 2004 Mar; 428(6979):182-5. PubMed ID: 15014500
[TBL] [Abstract][Full Text] [Related]
9. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
Earl PL; Americo JL; Wyatt LS; Espenshade O; Bassler J; Gong K; Lin S; Peters E; Rhodes L; Spano YE; Silvera PM; Moss B
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10889-94. PubMed ID: 18678911
[TBL] [Abstract][Full Text] [Related]
10. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
Edghill-Smith Y; Golding H; Manischewitz J; King LR; Scott D; Bray M; Nalca A; Hooper JW; Whitehouse CA; Schmitz JE; Reimann KA; Franchini G
Nat Med; 2005 Jul; 11(7):740-7. PubMed ID: 15951823
[TBL] [Abstract][Full Text] [Related]
11. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.
Iizuka I; Ami Y; Suzaki Y; Nagata N; Fukushi S; Ogata M; Morikawa S; Hasegawa H; Mizuguchi M; Kurane I; Saijo M
Jpn J Infect Dis; 2017 Jul; 70(4):408-415. PubMed ID: 28003603
[TBL] [Abstract][Full Text] [Related]
12. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
Edghill-Smith Y; Bray M; Whitehouse CA; Miller D; Mucker E; Manischewitz J; King LR; Robert-Guroff M; Hryniewicz A; Venzon D; Meseda C; Weir J; Nalca A; Livingston V; Wells J; Lewis MG; Huggins J; Zwiers SH; Golding H; Franchini G
J Infect Dis; 2005 Feb; 191(3):372-81. PubMed ID: 15633096
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
[TBL] [Abstract][Full Text] [Related]
14. Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.
Zielinski RJ; Smedley JV; Perera PY; Silvera PM; Waldmann TA; Capala J; Perera LP
Vaccine; 2010 Oct; 28(43):7081-91. PubMed ID: 20728526
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8.
Eto A; Saito T; Yokote H; Kurane I; Kanatani Y
Vaccine; 2015 Nov; 33(45):6106-11. PubMed ID: 26319072
[TBL] [Abstract][Full Text] [Related]
16. A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.
Artenstein AW; Johnson C; Marbury TC; Morrison D; Blum PS; Kemp T; Nichols R; Balser JP; Currie M; Monath TP
Vaccine; 2005 May; 23(25):3301-9. PubMed ID: 15837236
[TBL] [Abstract][Full Text] [Related]
17. Smallpox vaccine safety is dependent on T cells and not B cells.
Gordon SN; Cecchinato V; Andresen V; Heraud JM; Hryniewicz A; Parks RW; Venzon D; Chung HK; Karpova T; McNally J; Silvera P; Reimann KA; Matsui H; Kanehara T; Shinmura Y; Yokote H; Franchini G
J Infect Dis; 2011 Apr; 203(8):1043-53. PubMed ID: 21450994
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
[TBL] [Abstract][Full Text] [Related]
19. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
Nigam P; Earl PL; Americo JL; Sharma S; Wyatt LS; Edghill-Spano Y; Chennareddi LS; Silvera P; Moss B; Robinson HL; Amara RR
Virology; 2007 Sep; 366(1):73-83. PubMed ID: 17507071
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
